Reset filters
13 October 2026

Pulmonary arterial hypertension (PAH) is a chronic and progressive disease with substantial physiological and psychosocial burden. Effective patient education is essential for self-management and improved outcomes, yet access to reliable information remains limited by brief clinic visits and variable-quality external resources.

Pulmonary Circulation
13 October 2026

Pulmonary arterial hypertension (PAH) is a progressive and lethal disorder with limited therapeutic options. β-sitosterol, a plant compound, has shown potential in managing PAH, but its protective mechanisms remain unclear. We evaluated the protective effects of β-sitosterol against monocrotaline (MCT)-induced PAH in rats and explored the underlying mechanisms.

Pulmonary Circulation
30 September 2026

The first Global PH Consult case discussion webinar. Hear an anonymised complex PH case from Vietnam discussed by Minh Ly Nguyen and Tomas Pulido, moderated by Sandeep Sahay. This live webinar explored the challenges of managing severe pulmonary arterial hypertension in a setting with limited treatment options.

IDDI Workstream or Task Force Learning